Madrigal Pharmaceuticals, Inc. Financial Ratios — MDGL Stock

Profitability (USD)

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Return on Common Equity (%)	-247.72	-139.78	-145.29	-150.86	- -	- -	-28.49	-9.95	-18.79	-61.61	-110.92	-150.12	-123.98	-80.35	-42.49
Return on Assets (%)	-98.31	-86.4	-91	-87.97	-13.55	-126.95	-26.68	-9.68	-18.1	-55.48	-86.32	-92.89	-74.49	-55.37	-25.05
Return on Capital (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Return on Invested Capital (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Gross Margin (%)	100	100	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	96.54	94.14
EBITDA Margin (%)	-579.75	-40,954.42	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	-275.78	-31.16
Operating Margin (%)	-599.05	-41,456.46	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	-276.39	-31.31
Incremental Operating Margin (%)	- -	- -	18,107.48	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	-276.39
Pretax Margin (%)	-624.74	-42,714.29	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	-258.64	-30.08
Profit Margin (%)	-624.74	-42,714.29	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	-258.64	-30.08
Net Income to Common Margin (%)	-624.74	-42,714.29	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	-258.64	-30.08
Effective Tax Rate (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Dvd Payout Ratio (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Sustainable Growth Rate (%)	-247.72	-139.78	-145.29	-150.86	- -	- -	-28.49	-9.95	-18.79	-61.61	-110.92	-150.12	-123.98	-80.35	-42.49

Credit (USD)

Credit Ratios API ChatGPT

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Total Debt	17	12	23	14	49	- -	- -	- -	1	1	1	50	117	120	348
ST Debt	4	8	9	9	49	- -	- -	- -	- -	- -	- -	1	1	1	1
LT Debt	12	4	14	5	- -	- -	- -	- -	- -	- -	- -	49	117	119	347
Total Debt/EBITDA	-0.38	-0.21	-0.27	-0.17	-15.03	- -	- -	- -	-0.01	- -	- -	-0.17	-0.31	-0.24	-1.16
Net Debt/EBITDA	0.31	1.15	0.29	0.39	-14.94	0.76	4.65	1.41	0.49	0.26	0.15	0.96	-0.04	-0.04	-0.47
Total Debt/EBIT	-0.37	-0.2	-0.27	-0.17	-15.03	- -	- -	- -	-0.01	- -	- -	-0.17	-0.31	-0.24	-1.16
Net Debt/EBIT	0.3	1.13	0.29	0.38	-14.94	0.76	4.64	1.41	0.49	0.26	0.15	0.96	-0.04	-0.04	-0.47
EBITDA to Interest Expense	-22.57	-32.56	-33.06	-37.68	-0.9	-20.79	- -	- -	- -	- -	- -	-73.94	-29.89	-33.86	-13.38
EBITDA-CapEx/Interest Expense	-22.93	-32.83	-33.35	-37.75	-0.9	-20.8	- -	- -	- -	- -	- -	-74	-30.01	-34.3	-13.54
EBIT to Interest Expense	-23.32	-32.96	-33.25	-37.99	-0.9	-20.79	- -	- -	- -	- -	- -	-74.06	-29.93	-33.94	-13.45
Interest Expense	2	2	3	2	4	1	- -	- -	- -	- -	- -	4	13	15	22
Common Equity/Total Assets	34.91	72.87	51.56	64.7	-13,453.22	88.35	94.77	98.26	94.23	83.61	71.75	54.44	63.28	72.38	47.85
Long-Term Debt/Equity (%)	83.94	5.95	28.32	7.14	- -	- -	- -	- -	0.09	0.2	0.2	24.97	28.78	15.72	57.51
Long-Term Debt/Capital (%)	39.47	5.1	19.18	5.88	- -	- -	- -	- -	0.09	0.19	0.2	19.93	22.33	13.57	36.47
Long-Term Debt/Total Assets (%)	29.3	4.33	14.61	4.62	- -	- -	- -	- -	0.08	0.16	0.14	13.59	18.21	11.38	27.52
Total Debt/Equity (%)	112.68	16.52	47.66	21.35	-99.35	- -	- -	- -	0.16	0.33	0.41	25.28	28.91	15.85	57.68
Total Debt/Capital (%)	52.98	14.18	32.28	17.59	-15,272.23	- -	- -	- -	0.16	0.33	0.4	20.18	22.43	13.68	36.58
Total Debt/Total Assets (%)	39.33	12.04	24.58	13.81	13,365.71	- -	- -	- -	0.15	0.27	0.29	13.76	18.3	11.47	27.6
Net Debt to Equity	-91.06	-92.08	-51.37	-49.44	-98.72	-52.58	-81.55	-12.03	-11.21	-22.5	-18.49	-143	3.84	2.33	23.43
Net Debt/Capital (%)	-998.74	-1,160.58	-105.08	-97.53	-7,733.13	-110.89	-441.92	-13.67	-12.6	-28.92	-22.58	334.95	3.68	2.27	18.78
EBITDA	-44	-60	-87	-83	-3	-25	-32	-41	-95	-206	-242	-293	-380	-497	-299
EBITDA-CapEx	-45	-61	-88	-83	-3	-25	-32	-41	-95	-207	-242	-293	-381	-503	-302
Operating Income (Loss)	-45	-61	-88	-84	-3	-25	-32	-41	-95	-207	-242	-294	-380	-498	-300

Liquidity (USD)

Liquidity Ratios API ChatGPT

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Cash Ratio	2.62	4.28	2.84	3.16	0.01	8.44	19.05	57.29	17.47	6.1	3.52	3.1	5.35	5.47	3.17
Current Ratio	2.66	4.32	2.86	3.22	0.01	8.58	19.1	57.46	17.52	6.13	3.54	3.12	5.38	6.1	4.01
Quick Ratio	2.62	4.28	2.84	3.16	0.01	8.44	19.05	57.29	17.47	6.1	3.52	3.1	5.35	5.79	3.6
CFO/Avg Current Liab	-2.97	-2.8	-2.78	-2.5	-0.08	-0.65	-3	-2.76	-2.48	-4.4	-2.98	-2.33	-2.77	-3.17	-0.79
Common Equity/Total Assets	34.91	72.87	51.56	64.7	-13,453.22	88.35	94.77	98.26	94.23	83.61	71.75	54.44	63.28	72.38	47.85
Long-Term Debt/Equity (%)	83.94	5.95	28.32	7.14	- -	- -	- -	- -	0.09	0.2	0.2	24.97	28.78	15.72	57.51
Long-Term Debt/Capital (%)	39.47	5.1	19.18	5.88	- -	- -	- -	- -	0.09	0.19	0.2	19.93	22.33	13.57	36.47
Long-Term Debt/Total Assets (%)	29.3	4.33	14.61	4.62	- -	- -	- -	- -	0.08	0.16	0.14	13.59	18.21	11.38	27.52
Total Debt/Equity (%)	112.68	16.52	47.66	21.35	-99.35	- -	- -	- -	0.16	0.33	0.41	25.28	28.91	15.85	57.68
Total Debt/Capital (%)	52.98	14.18	32.28	17.59	-15,272.23	- -	- -	- -	0.16	0.33	0.4	20.18	22.43	13.68	36.58
Total Debt/Total Assets (%)	39.33	12.04	24.58	13.81	13,365.71	- -	- -	- -	0.15	0.27	0.29	13.76	18.3	11.47	27.6
CFO/Total Liabilities	-171.69	-193.68	-167.88	-222.08	-6.38	-366.83	-221.97	-302.07	-163.29	-335.06	-238.16	-136.13	-137.84	-158.26	-28.86
CFO/CapEx	-68.55	-107.2	-100.66	-548.09	- -	-5,869.33	-178.54	-1,159.41	-242	-471.74	-879.99	-1,036.21	-219.22	-70.5	-54.67
Altman's Z-Score	-10.79	6.04	-4.58	-5.92	-378.56	18.74	77.75	123.92	32.8	18.54	5.77	13.51	7.82	11.31	10.68

Working Capital (USD)

Working Capital Ratios API ChatGPT

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Accounts Receivable Turnover	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	6.69	10.18
Days Sales Outstanding	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	54.53	35.86
Inventory Turnover	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	0.37	1.03
Days Inventory Outstanding	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	997.5	353.99
Accounts Payable Turnover	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	1.13	2.1
Accounts Payable Turnover Days	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	324.42	174.13
Cash Conversion Cycle	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	727.61	215.71
Inventory to Cash Days	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	-942.97	-318.14
Inventories	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	34	75
Raw Materials	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Work In Process	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	30	68
Finished Goods	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	5	7
Other Inventory	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -

Enterprise Value (USD)

Enterprise Value API ChatGPT

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Market Capitalization	231	622	447	289	48	178	1,306	1,737	1,406	1,724	1,449	5,254	4,599	6,790	13,302
- Cash & Cash Equivalents	30	82	48	46	- -	19	149	57	47	54	36	332	100	100	199
+ Preferred Equity and Hybrid Capital	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Minority/Non Controlling Interest	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Total Debt	17	12	23	14	49	- -	- -	- -	1	1	1	50	117	120	348
Enterprise Value	208	534	379	205	97	138	1,114	1,253	967	1,441	1,180	4,945	4,082	5,983	12,666
Total Capital	31	87	72	79	- -	36	182	477	417	241	197	247	523	874	950
Total Debt/Capital (%)	52.98	14.18	32.28	17.59	-15,272.23	- -	- -	- -	0.16	0.33	0.4	20.18	22.43	13.68	36.58
Total Debt / EV	0.08	0.02	0.06	0.07	0.5	- -	- -	- -	- -	- -	- -	0.01	0.03	0.02	0.03
EV/Sales	27.46	3,629.54	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	33.22	13.22
EV/EBITDA	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
EV/EBIT	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
EV/Cash Flow to Firm	- -	- -	- -	- -	205.3	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
EV/Free Cash Flow to Firm	- -	- -	- -	- -	205.3	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Diluted Market Cap	220	536	372	261	2	78	1,124	1,668	1,403	1,717	1,401	4,974	4,324	6,564	13,064
Diluted Enterprise Value	207	467	347	229	50	58	975	1,611	1,357	1,664	1,366	4,692	4,341	6,584	13,213
EV per Share	147.15	270.92	155.44	65.88	24.52	11.51	78.33	81.33	62.7	92.9	68.98	273.19	205.37	271.91	554.5
TTM Sales	8	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	180	958
TTM EBITDA	-44	-60	-87	-83	-3	-25	-32	-41	-95	-206	-242	-293	-380	-497	-299
TTM Operating Income	-45	-61	-88	-84	-3	-25	-32	-41	-95	-207	-242	-294	-380	-498	-300
TTM Cash Flow to Firm	-45	-52	-75	-77	- -	-16	-22	-26	-42	-158	-184	-221	-312	-441	-167
TTM Free Cash Flow to Firm	-45	-52	-74	-77	- -	-16	-22	-25	-41	-157	-184	-221	-310	-434	-164

Multiples (USD)

Valuation Multiples API ChatGPT

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Price/Free Cash Flow	-4.73	-9.99	-4.85	-3.31	-0.67	-4.4	-50.65	-65.45	-33.84	-10.92	-7.63	-22.14	-13.4	-14.62	-70.21
EV/EBIT	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Enterprise Value	208	534	379	205	97	138	1,114	1,253	967	1,441	1,180	4,945	4,082	5,983	12,666
Low Price	105.7	124.95	129.5	88.9	10.15	5.25	13.09	90.56	82.31	56.82	68.56	52.33	119.76	168.25	265
EV/Sales	27.46	3,629.54	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	33.22	13.22
EV/EBITDA	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Price/Earnings	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Price/Earnings Average	-4.66	-5.88	-5.57	-4.76	-1.67	-2.28	-10.55	-79.64	-19.31	-7.89	-6.88	-4.71	-11.32	-11.55	-29.49
Price/Earnings High	-6.9	-9.32	-9.35	-8.25	-2.77	-3.6	-39.7	-147.01	-27.17	-10.48	-9.75	-18.3	-16.14	-16.82	-47.86
Price/Earnings Low	-3.01	-3.38	-2.91	-2.9	-0.25	-1.04	-5.14	-40.84	-15.09	-4.34	-4.69	-3.04	-5.99	-7.68	-20.62
Price/Book Value	15.66	8.28	9.1	4.44	-0.99	4.89	7.17	3.64	3.37	7.18	7.39	26.62	11.35	9	22.07
Price/Book Value Average	15.69	5.71	12.3	6.98	-5.4	3.79	2.1	5.71	3.9	6.68	8.78	7.45	11.1	7.38	14.36
Price/Book Value High	23.24	9.04	20.63	12.1	-8.93	5.99	7.88	10.53	5.49	8.87	12.44	28.93	15.82	10.74	23.31
Price/Book Value Low	10.13	3.28	6.42	4.26	-0.82	1.72	1.02	2.93	3.05	3.67	5.98	4.8	5.87	4.91	10.04
Price/Tangible Book Value	15.66	8.28	9.1	4.44	-0.99	4.89	7.17	3.64	3.37	7.18	7.39	26.62	11.35	9.06	22.34
Price/Tangible Book Value Average	15.69	5.71	12.3	6.98	-5.4	3.79	2.1	5.71	3.9	6.68	8.78	7.45	11.1	7.42	14.54
Price/Tangible Book Value High	23.24	9.04	20.63	12.1	-8.93	5.99	7.88	10.53	5.49	8.87	12.44	28.93	15.82	10.81	23.6
Price/Tangible Book Value Low	10.13	3.28	6.42	4.26	-0.82	1.72	1.02	2.93	3.05	3.67	5.98	4.8	5.87	4.94	10.17
Price/Sales	29.06	3,645.47	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	36.44	13.63
Price/Sales Average	29.13	2,511.98	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	29.87	8.87
Price/Sales High	43.13	3,980.91	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	43.49	14.4
Price/Sales Low	18.79	1,442.83	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	19.87	6.2
Price/Cash Flow	-4.66	-9.9	-4.8	-3.31	-0.67	-4.4	-50.36	-65.39	-33.7	-10.9	-7.62	-22.12	-13.34	-14.41	-68.92
Price/Cash Flow Average	-4.67	-6.82	-6.49	-5.2	-3.65	-3.41	-14.73	-102.45	-38.95	-10.13	-9.05	-6.19	-13.04	-11.81	-44.86
Price/Cash Flow High	-6.91	-10.81	-10.89	-9.01	-6.04	-5.39	-55.42	-189.1	-54.8	-13.46	-12.82	-24.04	-18.6	-17.2	-72.79
Price/Cash Flow Low	-3.01	-3.92	-3.39	-3.17	-0.55	-1.55	-7.18	-52.53	-30.44	-5.57	-6.16	-3.99	-6.9	-7.86	-31.36
Price/Free Cash Flow Average	-4.74	-6.89	-6.56	-5.21	-3.65	-3.41	-14.81	-102.54	-39.12	-10.15	-9.06	-6.2	-13.1	-11.98	-45.69
Price/Free Cash Flow High	-7.02	-10.91	-11	-9.03	-6.04	-5.39	-55.73	-189.27	-55.03	-13.49	-12.84	-24.06	-18.68	-17.44	-74.14
Price/Free Cash Flow Low	-3.06	-3.95	-3.43	-3.18	-0.55	-1.55	-7.22	-52.58	-30.57	-5.58	-6.17	-3.99	-6.93	-7.97	-31.95
EV/Sales Average	28.8	2,444.3	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	31.01	9.19
EV/Sales High	43.5	4,148.58	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	45.1	14.81
EV/Sales Low	17.96	1,203.85	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	20.66	6.47
EV/EBITDA Average	-4.97	-5.97	-6.65	-5.07	-96.57	-4.71	-7.29	-65.64	-16.65	-7.51	-6.96	-4.06	-11.88	-11.24	-29.49
EV/EBITDA High	-7.5	-10.13	-11.34	-9.07	-150.04	-7.88	-40.28	-122.35	-23.62	-10.07	-9.93	-18.52	-16.92	-16.35	-47.55
EV/EBITDA Low	-3.1	-2.94	-3.33	-2.94	-27.3	-1.73	-1.18	-32.97	-12.9	-4.02	-4.7	-2.27	-6.31	-7.49	-20.77
EV/EBIT Average	-4.81	-5.9	-6.61	-5.03	-96.57	-4.71	-7.28	-65.48	-16.63	-7.49	-6.95	-4.05	-11.86	-11.22	-29.35
EV/EBIT High	-7.26	-10.01	-11.28	-9	-150.04	-7.88	-40.18	-122.06	-23.59	-10.04	-9.91	-18.49	-16.9	-16.32	-47.31
EV/EBIT Low	-3	-2.9	-3.32	-2.92	-27.3	-1.73	-1.17	-32.89	-12.89	-4.01	-4.69	-2.27	-6.3	-7.48	-20.67
Last Price	163.45	315.7	183.4	92.75	12.25	14.9	91.79	112.72	91.11	111.17	84.74	290.25	231.38	308.57	582.34
High Price	242.55	344.75	415.8	252.7	110.95	18.24	101	325.98	148.18	137.28	142.62	315.45	322.67	368.29	615
Enterprise Value Average	218	359	579	422	312	119	233	2,664	1,579	1,549	1,685	1,189	4,515	5,586	8,806
Enterprise Value High	330	610	987	756	485	199	1,288	4,966	2,240	2,076	2,404	5,429	6,430	8,124	14,197
Enterprise Value Low	136	177	290	245	88	44	38	1,338	1,224	828	1,137	666	2,398	3,722	6,202

Shares Outstanding	1	2	2	3	4	12	14	15	15	16	17	18	20	22	23
Diluted Weighted Avg Shares	1	2	2	3	- -	5	12	15	15	15	17	17	19	21	22
Basic Weighted Avg Shares	1	2	2	3	- -	5	12	15	15	15	17	17	19	21	22
Revenue per Share	5.62	0.09	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	8.47	42.72
EBITDA per Share	-32.61	-35.47	-42.92	-29.59	-18.9	-4.85	-2.61	-2.74	-6.16	-13.35	-14.64	-17.1	-20.33	-23.35	-13.31
Operating Income per Share	-33.69	-35.9	-43.18	-29.83	-18.9	-4.85	-2.62	-2.75	-6.17	-13.38	-14.66	-17.13	-20.36	-23.4	-13.38
Basic EPS, GAAP	-35.14	-36.99	-44.48	-30.62	-40.03	-5.07	-2.54	-2.22	-5.45	-13.09	-14.63	-17.23	-19.99	-21.9	-12.85
Basic EPS from Cont Ops	- -	- -	- -	- -	-40.03	-5.07	- -	- -	- -	- -	- -	- -	- -	- -	- -
Diluted EPS, GAAP	-35.14	-36.99	-44.48	-30.62	-40.03	-5.07	-2.54	-2.22	-5.45	-13.09	-14.63	-17.23	-19.99	-21.9	-12.85
Diluted EPS from Cont Ops	- -	- -	- -	- -	-40.03	-5.07	- -	- -	- -	- -	- -	- -	- -	- -	- -
Dividend per Share	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Cash Flow per Share	-35.08	-31.89	-38.17	-28.05	-18.37	-3.38	-1.82	-1.72	-2.7	-10.2	-11.12	-13.12	-17.35	-21.42	-8.45
Free Cash Flow per Basic Share	-35.59	-32.19	-38.55	-28.1	-18.37	-3.38	-1.83	-1.73	-2.71	-10.22	-11.14	-13.13	-17.43	-21.72	-8.6
Cash & Equivalents per Share	28.07	51.08	37.56	31.33	0.08	3.39	13.46	31.39	28.46	18.32	15.81	19.82	31.91	42.09	43.06
Book Value per Share	10.44	38.12	20.16	20.89	-12.42	3.05	12.81	30.95	27	15.47	11.47	10.9	20.39	34.28	26.39
Tangible Book Value per Share	10.44	38.12	20.16	20.89	-12.42	3.05	12.81	30.95	27	15.47	11.47	10.9	20.39	34.07	26.06

Madrigal Pharmaceuticals, Inc.

Profitability (USD)

Credit (USD)

Liquidity (USD)

Working Capital (USD)

Enterprise Value (USD)

Multiples (USD)

Per Share Data Items (USD)